Inside Precision Medicine Marketplace Molecular Diagnostics CytoSure™ Constitutional NGS

Oxford Gene Technology
CytoSure™ Constitutional NGS

CytoSure™ Constitutional NGS assay is as effective as a microarray in calling CNVs and LOH, with the additional ability to be able to detect SNVs and Indels. This ability to detect CNVs, SNVs, Indels and LOH in a single, robust assay reduces analytical cost and burden as well as cutting the overall time taken to deliver a result. OGT has developed an intuitive and user-friendly analytical software, Interpret, which includes a proprietary CNV calling algorithm. With array users in mind, Interpret offers familiar visualisation and interpretation tools alongside an intuitive web interface. With our class-leading support teams, you can now transition your ID / DD analysis from arrays to NGS with confidence.




Oxford Gene Technology

Begbroke Science Park
Begbroke Hill, Woodstock Road Begbroke, Oxfordshire OX5 1PF, UK
+44 (0)1865 856800
https://www.ogt.com





Features & Specs

CytoSure Constitutional NGS solution delivers:

  • The ability to detect CNV, SNV, indel, LOH, mosaicism – everything you get from arrays and NGS in a single assay
  • Advanced panel design and complimentary software – robust single-exon CNV calling unlike other large targeted panels or exomes
  • The most up-to-date content for ID and DD – giving you the best chance to identify the aberration of interest
  • A targeted >700-gene panel, minimising variants of uncertain significance (VUS) detection – helping you to minimise analysis time
  • Cost-effective analysis – don’t spend time and effort sequencing, storing and analysing data that is not relevant

Features & Specs

CytoSure Constitutional NGS solution delivers:

  • The ability to detect CNV, SNV, indel, LOH, mosaicism – everything you get from arrays and NGS in a single assay
  • Advanced panel design and complimentary software – robust single-exon CNV calling unlike other large targeted panels or exomes
  • The most up-to-date content for ID and DD – giving you the best chance to identify the aberration of interest
  • A targeted >700-gene panel, minimising variants of uncertain significance (VUS) detection – helping you to minimise analysis time
  • Cost-effective analysis – don’t spend time and effort sequencing, storing and analysing data that is not relevant
Inside Precision Medicine